摘要
-甲胎蛋白(AFP)是一种69kDd的胎和肿瘤相关的单链糖蛋白,属于类白藜芦醇基因家族。AFP作为载体/转运分子以及生长调节剂,已被用作胎儿缺陷和癌症生长的临床生物标志物。溶血磷脂(LPL)是由附着在极性头基上的小分子量单酰基碳链(棕榈酸、油酸)组成的质膜衍生的生物活性脂质信号传导介质,它们的分子量范围250-750道尔顿。 LPL由鞘氨醇1-磷酸或溶血磷脂酸组成,主要由其胆碱,乙醇胺,丝氨酸或肌醇衍生物组成。它们只存在于脊椎动物中。这些生物活性旁分泌脂质介质普遍分布在组织中,并从涉及发育,生理和病理过程的许多不同细胞类型(血小板,巨噬细胞,单核细胞等)释放。 LPL与本文所述的四种不同类型的G-蛋白偶联受体结合,其转化多种细胞效应,其包括诸如形态发生,神经发育,血管发生和癌发生之类的活性。通过计算机模拟分析,鉴定了AFP第三结构域受体结合片段上LPL受体的潜在结合位点。可以想象,但未被证明,AFP可能不仅与LPL受体结合,而且也与LPL本身结合,因为AFP结合中长链脂肪酸。提出过去一些归于AFP的活动可能部分是由于存在结合的LPL和/或其受体。
关键词: α-甲胎蛋白,结合蛋白,细胞靶点,树突细胞,碎片,溶血磷脂,单细胞/巨噬细胞,受体
Current Drug Targets
Title:Review of the Third Domain Receptor Binding Fragment of Alphafetoprotein (AFP): Plausible Binding of AFP to Lysophospholipid Receptor Targets
Volume: 18 Issue: 7
关键词: α-甲胎蛋白,结合蛋白,细胞靶点,树突细胞,碎片,溶血磷脂,单细胞/巨噬细胞,受体
摘要: Alpha-fetoprotein (AFP) is a 69 kD fetal- and tumor-associated single-chain glycoprotein belonging to the albuminoid gene family. AFP functions as a carrier/transport molecule as well as a growth regulator and has been utilized as a clinical biomarker for both fetal defects and cancer growth. Lysophospholipids (LPLs) are plasma membrane-derived bioactive lipid signaling mediators composed of a small molecular weight single acyl carbon chain (palmitic, oleic acid) attached to a polar headgroup; they range in molecular mass from 250-750 daltons. The LPLs consist of either sphingosine-1-phosphate or lysophosphatidic acid, and mostly their choline, ethanolamine, serine or inositol derivatives. They are present only in vertebrates. These bioactive paracrine lipid mediators are ubiquitously distributed in tissues and are released from many different cell types (platelets, macrophages, monocytes, etc.) involved in developmental, physiological, and pathological processes. The LPLs bind to four different classes of G-protein coupled receptors described herein which transduce a multiple of cell effects encompassing activities such as morphogenesis, neural development, angiogenesis, and carcinogenesis. The identification of potential binding sites of LPL receptors on the AFP third domain receptor binding fragment was derived by computer modeling analysis. It is conceivable, but not proven, that AFP might bind not only to the LPL receptors, but also to LPLs themselves since AFP binds medium and long chain fatty acids. It is proposed that some of the activities ascribed to AFP in the past might be due in part to the presence of bound LPLs and/or their receptors.
Export Options
About this article
Cite this article as:
Review of the Third Domain Receptor Binding Fragment of Alphafetoprotein (AFP): Plausible Binding of AFP to Lysophospholipid Receptor Targets, Current Drug Targets 2017; 18 (7) . https://dx.doi.org/10.2174/1389450117666160201105245
DOI https://dx.doi.org/10.2174/1389450117666160201105245 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
RNA Molecules in the Treatment of Human Diseases
Messenger and non-coding RNAs, including long and small transcripts, are mediators of gene expression. Gene expression at the RNA level shows significant aberrations in human diseases, including cancer, leukemia, lymphoma, cardiovascular diseases, and neurological disorders. Human transcripts serve either as biomarkers of diagnosis, prognosis, prediction of treatment response and/or therapy ...read more
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Thymoquinone Anticancer Discovery: Possible Mechanisms
Current Drug Discovery Technologies Nicotine, Body Weight and Potential Implications in the Treatment of Obesity
Current Topics in Medicinal Chemistry RGD-based Therapy: Principles of Selectivity
Current Pharmaceutical Design Transglutaminase-Catalyzed Crosslinking in Neurological Disease: From Experimental Evidence to Therapeutic Inhibition
CNS & Neurological Disorders - Drug Targets Oxidative Phosphorylation as a Target to Arrest Malignant Neoplasias
Current Medicinal Chemistry Involvement of Uridine-Nucleotide-Stimulated P2Y Receptors in Neuronal Growth and Function
Central Nervous System Agents in Medicinal Chemistry Target Driven Preclinical Screening for New Antimitotic Chemotherapy Agents
Current Topics in Medicinal Chemistry The Paradox of Oestradiol-Induced Breast Cancer Cell Growth and Apoptosis
Current Signal Transduction Therapy Posttranslational Modifications as Versatile Regulators of Parkin Function
Current Medicinal Chemistry Emerging Synergisms Between Drugs and Physiologically-Patterned Weak Magnetic Fields: Implications for Neuropharmacology and the Human Population in the Twenty-First Century
Current Neuropharmacology New Generation of Liposomal Drugs for Cancer
Anti-Cancer Agents in Medicinal Chemistry Gene Transfer with Sequence-Defined Oligo(ethanamino)amides Bioreducibly Attached to a Propylenimine Dendrimer Core
Pharmaceutical Nanotechnology Dynamic Crosstalk between GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription and Human Disease
Current Signal Transduction Therapy Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance
Current Drug Targets Nuclear Factor-κB: A Holy Grail in Cancer Prevention and Therapy
Current Signal Transduction Therapy Amyloid Beta Peptide, 4-Hydroxynonenal and Apoptosis
Current Alzheimer Research Antitumor Activities of Interleukin-27 on Melanoma
Endocrine, Metabolic & Immune Disorders - Drug Targets Predicting Hub Genes of Glioblastomas Based on a Support Vector Machine Combined with CFS Algorithms
Current Bioinformatics Unveiling the Molecular Mechanism of Diosmetin and its Impact on Multifaceted Cellular Signaling Pathways
Protein & Peptide Letters EGF Receptor as a Drug Target in Arterial Hypertension
Mini-Reviews in Medicinal Chemistry